M. P. LAMONTAGNE

410 total citations
24 papers, 317 citations indexed

About

M. P. LAMONTAGNE is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, M. P. LAMONTAGNE has authored 24 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in M. P. LAMONTAGNE's work include Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and biological activity (6 papers) and Chemical Reaction Mechanisms (6 papers). M. P. LAMONTAGNE is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and biological activity (6 papers) and Chemical Reaction Mechanisms (6 papers). M. P. LAMONTAGNE collaborates with scholars based in . M. P. LAMONTAGNE's co-authors include A. Markovac, Peter Blumbergs, David C. Smith, Bernard T. Gillis, Muhammad S. Khan, Calvin L. Stevens, Carol H. Collins, Jaroslav Novotný and Min Ao and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Journal of Heterocyclic Chemistry.

In The Last Decade

M. P. LAMONTAGNE

23 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. P. LAMONTAGNE 11 225 88 70 37 20 24 317
Jacques Bompart France 11 243 1.1× 141 1.6× 137 2.0× 51 1.4× 21 1.1× 25 425
A. Markovac Canada 10 211 0.9× 165 1.9× 39 0.6× 24 0.6× 26 1.3× 23 370
GB Barlin Australia 11 262 1.2× 120 1.4× 45 0.6× 18 0.5× 10 0.5× 59 353
Adina Ryckebusch France 9 277 1.2× 139 1.6× 76 1.1× 48 1.3× 27 1.4× 11 384
Donald F. Worth United States 14 382 1.7× 225 2.6× 98 1.4× 32 0.9× 67 3.4× 48 640
Peter Smith South Africa 7 113 0.5× 89 1.0× 54 0.8× 20 0.5× 8 0.4× 7 239
Roger Escale France 12 253 1.1× 115 1.3× 68 1.0× 7 0.2× 21 1.1× 38 379
Chitalu C. Musonda South Africa 9 225 1.0× 104 1.2× 115 1.6× 36 1.0× 20 1.0× 11 338
Suryanarayana Vangapandu India 8 239 1.1× 211 2.4× 90 1.3× 34 0.9× 23 1.1× 10 437
C. DeWitt Blanton United States 10 213 0.9× 96 1.1× 24 0.3× 11 0.3× 38 1.9× 41 318

Countries citing papers authored by M. P. LAMONTAGNE

Since Specialization
Citations

This map shows the geographic impact of M. P. LAMONTAGNE's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. LAMONTAGNE with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. LAMONTAGNE more than expected).

Fields of papers citing papers by M. P. LAMONTAGNE

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. LAMONTAGNE. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. LAMONTAGNE. The network helps show where M. P. LAMONTAGNE may publish in the future.

Co-authorship network of co-authors of M. P. LAMONTAGNE

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. LAMONTAGNE. A scholar is included among the top collaborators of M. P. LAMONTAGNE based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. LAMONTAGNE. M. P. LAMONTAGNE is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LAMONTAGNE, M. P., Peter Blumbergs, & David C. Smith. (1989). Antimalarials. 16. Synthesis of 2-substituted analogs of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline as candidate antimalarials. Journal of Medicinal Chemistry. 32(8). 1728–1732. 40 indexed citations
2.
LAMONTAGNE, M. P., et al.. (1987). Preparation of carbon 14‐labelled “Spy Dust” 5‐(4‐nitrophenyl)‐2,4‐[5‐14C]pentadienal, (NPPD). Journal of Labelled Compounds and Radiopharmaceuticals. 24(11). 1313–1316. 1 indexed citations
3.
LAMONTAGNE, M. P. & Peter Blumbergs. (1984). Antimalarials. 15. Side‐chain analogues of 8‐(4‐amino‐1‐methylbutylamino)‐6‐methoxy‐4‐methyl‐5‐(3‐trifluoromethylphenoxy)quinoline. Journal of Heterocyclic Chemistry. 21(1). 33–35. 1 indexed citations
4.
LAMONTAGNE, M. P., et al.. (1983). Preparation of 7‐substituted pyrrolo [2,3‐d] pyrimidines and 9‐substituted purines as potential antiparasitic agents. Journal of Heterocyclic Chemistry. 20(2). 295–299. 6 indexed citations
5.
LAMONTAGNE, M. P., A. Markovac, & Muhammad S. Khan. (1982). Antimalarials. 13. 5-Alkoxy analogs of 4-methylprimaquine. Journal of Medicinal Chemistry. 25(8). 964–968. 30 indexed citations
6.
LAMONTAGNE, M. P., et al.. (1982). Antimalarials. 14. 5-(Aryloxy)-4-methylprimaquine analogs. A highly effective series of blood and tissue schizonticidal agents. Journal of Medicinal Chemistry. 25(9). 1094–1097. 40 indexed citations
7.
LAMONTAGNE, M. P., et al.. (1980). Analogs of 8-[[6-(diethylamino)hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents. Journal of Medicinal Chemistry. 23(9). 981–985. 10 indexed citations
8.
Markovac, A. & M. P. LAMONTAGNE. (1980). Antimalarials. 12. Preparation of carbon isosteres of selected 4-pyridinemethanols as suppressive antimalarials. Journal of Medicinal Chemistry. 23(11). 1198–1201. 13 indexed citations
9.
LAMONTAGNE, M. P., et al.. (1979). Antimalarials. 11. Synthesis of 3- and 5-aminoquinolines as potential antimalarials. Journal of Medicinal Chemistry. 22(8). 1005–1008. 14 indexed citations
10.
LAMONTAGNE, M. P., et al.. (1977). Antimalarials. 10. Synthesis of 4-substituted primaquine analogs as candidate antimalarials. Journal of Medicinal Chemistry. 20(9). 1122–1127. 11 indexed citations
11.
LAMONTAGNE, M. P., et al.. (1976). Antimalarials. 8. Synthesis of amino ethers as candidate antimalarials. Journal of Medicinal Chemistry. 19(3). 360–365. 8 indexed citations
12.
Markovac, A. & M. P. LAMONTAGNE. (1976). Antimalarials. 9. Methylthio- and methylsulfonyl-substituted 9-phenanthrenemethanols. Journal of Medicinal Chemistry. 19(7). 978–982. 3 indexed citations
13.
LAMONTAGNE, M. P., A. Markovac, & Peter Blumbergs. (1974). Antimalarials. 6. Synthesis, antimalarial activity, and configurations of racemic .alpha.-(2-piperidyl)-4-pyridinemethanols. Journal of Medicinal Chemistry. 17(5). 519–523. 9 indexed citations
14.
LAMONTAGNE, M. P., A. Markovac, & Min Ao. (1973). Antimalarials. 5. 2-Aryl-6-trifluoromethy-1-4-pyridinemethanols. Journal of Medicinal Chemistry. 16(9). 1040–1041. 4 indexed citations
15.
LAMONTAGNE, M. P.. (1973). Antimalarials. 4. 4-Pyridinemethanols with styryl and benzoyl substituents. Journal of Medicinal Chemistry. 16(1). 68–72. 2 indexed citations
16.
Markovac, A., et al.. (1972). Antimalarials. 3. 2,6-Bis(aryl)-4-pyridinemethanols with trifluoromethyl substituents. Journal of Medicinal Chemistry. 15(9). 918–922. 9 indexed citations
17.
Blumbergs, Peter, et al.. (1972). Antimalarials. 2. 2,6-Bis(aryl)-4-pyridinemethanols. Journal of Medicinal Chemistry. 15(8). 808–812. 7 indexed citations
18.
Gillis, Bernard T. & M. P. LAMONTAGNE. (1968). Oxidation of hydrazones. III. .alpha.,.beta.-Unsaturated monoalkylhydrazones. The Journal of Organic Chemistry. 33(2). 762–766. 13 indexed citations
19.
Gillis, Bernard T. & M. P. LAMONTAGNE. (1968). Oxidation of azines with lead tetraacetate. II. The Journal of Organic Chemistry. 33(3). 1294–1295. 4 indexed citations
20.
Gillis, Bernard T. & M. P. LAMONTAGNE. (1967). Oxidation of azines with lead tetraacetate. The Journal of Organic Chemistry. 32(11). 3318–3320. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Bompart Breakdown of academic impact, for papers by A. Markovac Breakdown of academic impact, for papers by GB Barlin Breakdown of academic impact, for papers by Adina Ryckebusch Breakdown of academic impact, for papers by Donald F. Worth Breakdown of academic impact, for papers by Peter Smith Breakdown of academic impact, for papers by Roger Escale Breakdown of academic impact, for papers by Chitalu C. Musonda Breakdown of academic impact, for papers by Suryanarayana Vangapandu Breakdown of academic impact, for papers by C. DeWitt Blanton
Rankless by CCL
2026